{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:32:19Z","timestamp":1791027139441,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.mehy.2007.08.032","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T14:10:55Z","timestamp":1205331055000},"page":"53-57","source":"Crossref","is-referenced-by-count":46,"title":["The \u201cmetabolovirus\u201d model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon"],"prefix":"10.1016","volume":"71","author":[{"given":"Amir","family":"Shlomai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Shaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2007.08.032_bib1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection \u2013 natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2007.08.032_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/j.1460-2075.1985.tb03646.x","article-title":"A human hepatitis B viral enhancer element","volume":"4","author":"Shaul","year":"1985","journal-title":"EMBO J"},{"key":"10.1016\/j.mehy.2007.08.032_bib3","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1073\/pnas.041479698","article-title":"Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism","volume":"98","author":"Tang","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.mehy.2007.08.032_bib4","doi-asserted-by":"crossref","first-page":"8937","DOI":"10.1128\/JVI.75.19.8937-8948.2001","article-title":"Replication of the wild type and a natural hepatitis B virus nucleocapsid promoter variant is differentially regulated by nuclear hormone receptors in cell culture","volume":"75","author":"Tang","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2007.08.032_bib5","doi-asserted-by":"crossref","first-page":"9366","DOI":"10.1128\/JVI.71.12.9366-9374.1997","article-title":"Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily","volume":"71","author":"Yu","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2007.08.032_bib6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1128\/MCB.24.4.1799-1808.2004","article-title":"Enhancer I predominance in hepatitis B virus gene expression","volume":"24","author":"Doitsh","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.mehy.2007.08.032_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molmed.2004.09.004","article-title":"HNF-4[alpha]: from MODY to late-onset type 2 diabetes","volume":"10","author":"Gupta","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.mehy.2007.08.032_bib8","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1073\/pnas.0730870100","article-title":"Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis","volume":"100","author":"Rhee","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.mehy.2007.08.032_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/35093050","article-title":"Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1","volume":"413","author":"Yoon","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2007.08.032_bib10","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1073\/pnas.0607837103","article-title":"PGC-1{alpha} controls hepatitis B virus through nutritional signals","volume":"103","author":"Shlomai","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.mehy.2007.08.032_bib11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature03967","article-title":"The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism","volume":"437","author":"Koo","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2007.08.032_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","article-title":"AMP-activated protein kinase induces a p53-dependent metabolic checkpoint","volume":"18","author":"Jones","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.mehy.2007.08.032_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.icb.7100009","article-title":"Immunopathogenesis of hepatitis B virus infection","volume":"85","author":"Chang","year":"2006","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.mehy.2007.08.032_bib14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/jhep.2003.50453","article-title":"Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection","volume":"38","author":"David Milich","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.mehy.2007.08.032_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.genet.40.110405.090603","article-title":"Interplay of circadian clocks and metabolic rhythms","volume":"40","author":"Wijnen","year":"2006","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.mehy.2007.08.032_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature05767","article-title":"Transcriptional coactivator PGC-1[agr] integrates the mammalian clock and energy metabolism","volume":"447","author":"Liu","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2007.08.032_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11307-005-0019-y","article-title":"Circadian regulation of a viral gene promoter in live transgenic mice expressing firefly luciferase","volume":"7","author":"Collaco","year":"2005","journal-title":"Mol Imag Biol"},{"key":"10.1016\/j.mehy.2007.08.032_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.mehy.2006.08.018","article-title":"A circadian model for viral persistence","volume":"68","author":"Shadan","year":"2007","journal-title":"Med Hypoth"},{"key":"10.1016\/j.mehy.2007.08.032_bib19","first-page":"559","article-title":"Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma","volume":"7","author":"Evans","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.mehy.2007.08.032_bib20","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/sj.onc.1201444","article-title":"Repression of hepatitis B virus (HBV) transgene and HBV-induced liver injury by low protein diet","volume":"15","author":"Hu","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.mehy.2007.08.032_bib21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/07357900600815232","article-title":"Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of lamivudine prophylaxis","volume":"24","author":"Coiffier","year":"2006","journal-title":"Cancer Invest"},{"key":"10.1016\/j.mehy.2007.08.032_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2141.2006.06465.x","article-title":"Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies","volume":"136","author":"Lalazar","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.mehy.2007.08.032_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.20471","article-title":"Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy \u2013 a prospective case series","volume":"80","author":"Vassiliadis","year":"2005","journal-title":"Am J Hematol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698770800042X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698770800042X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T21:40:30Z","timestamp":1588455630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698770800042X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S030698770800042X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2007.08.032","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}